Both in Pharmaceuticals
GRI Bio vs Cadrenal Therapeutics
Over the past year GRI returned −97.0% and CVKD returned −92.6%; their daily moves had a correlation of 0.05.
GRI −97.0% CVKD −92.6%Growth of $1, one year, split-adjusted
| Metric | GRI | CVKD |
|---|---|---|
| Price | $1.63 | $0.9479 |
| Market cap | $3.6M | $3.4M |
| Today | +2.85% | +0.59% |
| 1 month | −18.8% | −13.0% |
| 6 months | −27.1% | −83.0% |
| Year to date | −76.5% | −86.0% |
| 1 year | −97.1% | −92.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.9M | $2.4M |
| Dividend yield | — | — |
| Volatility (60d) | 134.4% | 86.9% |
| Short % of float | 3.0% | 9.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).